Molecular Determinants of Alphavirus Neurovirulence: Nucleotide and Deduced Protein Sequence Changes during Attenuation of Venezuelan Equine Encephalitis Virus
The nucleotide and deduced amino acid sequences of the structural proteins of the TC-83 vaccine strain of Venezuelan equine encephalitis (VEE) virus have been determined from a cDNA clone containing the 26S mRNA coding region. A cDNA clone encoding the equivalent region of the virulent parent VEE virus [Trinidad donkey strain (TRD)] has been sequenced previously. Comparison of the sequences of the TC-83 and TRD cDNA clones revealed 13 nucleotide differences. Neither the organization of the structural proteins (5′-capsid-E3-E2-6K-E1-3′) nor the length (3762 nucleotides) of the open reading frame coding for the viral polyprotein precursor was altered during attenuation. Of the 13 nucleotide differences between the cDNA clones of TC-83 and TRD, nine occurred in the dominant population of the respective genomic RNAs from plaque-purified viruses. Six of the nine mutations were clustered in the E2 surface glycoprotein gene. All five of the nucleotide changes which produced non-conservative amino acid substitutions in the encoded proteins were located in the E2 gene. Two mutations occurred in the E1 glycoprotein gene; one was silent and the other did not alter the chemical character of the E1 protein. One nucleotide difference was found in the non-coding region immediately preceding the 5′-end of the 26S mRNA. The E2 and non-coding region mutations are candidates for the molecular determinants of VEE virus neurovirulence.
BakerE. F.Jr,
SassoD. R.,
ManessK.,
PrichardW. D.,
ParkerR. L.1978; Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study. American Journal of Veterinary Research 39:1627–1631
BeaucageS. L.,
CaruthersM. H.1981; Deoxynucleotide phosphoramidites – a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Letters 22:1859–1862
BergeT. O.,
BanksI. S.,
TigerttW. D.1961; Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells. American Journal of Hygiene 73:209–218
BoschF. X.,
GartenW.,
KlenkH. D.,
RottR.1981; Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses. Virology 113:725–735
BurkeD. S.,
RamsburgH. H.,
EdelmanR.1977; Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. Journal of Infectious Diseases 136:354–359
DietzscholdB.,
WunnerW. H.,
WiktorT. J.,
LopesA. D.,
LafonM.,
SmithC. L.,
KoprowskiH.1983; Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences, U.S.A 80:70–74
EddyG. A.,
MartinD. H.,
ReevesW. C.,
JohnsonK. M.1972; Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Infection and Immunity 5:160–163
EminiE. A.,
WiebeM. E.1981; An attenuated mutant of Venezuelan encephalitis virus: biochemical alterations and their genetic association with attenuation. Virology 110:185–196
EvansD. M. A.,
DunnG.,
MinorP. D.,
SchildG. C.,
CannA. J.,
StanwayG.,
AlmondJ. W.,
CurreyK.,
Maizel J. V.Jr1985; Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature, London 314:548–550
FieldsB. N.,
GreeneM. I.1982; Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature, London 300:19–23
FillisC. A.,
CalisherC. H.1979; Neutralizing antibody response of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virus. Journal of Clinical Microbiology 10:544–549
FranceJ. K.,
WyrickB. C.,
TrentD. W.1979; Biochemical and antigenic comparisons of the envelope glycoproteins of Venezuelan equine encephalomyelitis virus strains. Journal of General Virology 44:725–740
GrootH.1972; The health and economic impact of Venezuelan equine encephalitis (VEE). In Venezuelan Encephalitis pp. 7–16 Sci. Pub. No. 243. Washington, D.C.: Pan American Health Organization;
HollandJ. J.1984; Continuum of change in RNA virus genomes. In Concepts in Viral Pathogenesis pp. 137–143 Edited by
NotkinsA. L.,
OldstoneM. B. A.
New York: Springer-Verlag;
JahrlingP. B.,
SchererW. F.1973a; Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses. American Journal of Pathology 72:25–34
JahrlingP. B.,
SchererW. F.1973b; Homogeneity of Venezuelan encephalitis virion populations of hamster- virulent and benign strains, including the attenuated TC 83 vaccine. Infection and Immunity 7:905–910
JahrlingP. B.,
SchererW. F.1973c; Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters. Infection and Immunity 8:456–462
KawaokaY.,
NaeveC. W.,
WebsterR. G.1984; Is virulence of N5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?. Virology 139:303–316
KinneyR. M.,
TrentD. W.,
FranceJ. K.1983; Comparative immunological and biochemical analyses of viruses in the Venezuelan equine encephalitis complex. Journal of General Virology 64:135–147
KinneyR. M.,
JohnsonB. J. B.,
BrownV. L.,
TrentD. W.1986; Nucleotide sequence of the 26S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins. Virology (in press)
Le BlancP. A.,
SchererW. F.,
SussdorfD. H.1978; Infections of congenitally athymic (nude) and normal mice with avirulent and virulent strains of Venezuelan encephalitis virus. Infection and Immunity 21:779–785
MckinneyR. W.,
BergeT. O.,
SawyerW. D.,
TigerttW. D.,
CrozierD.1963; Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man. American Journal of Tropical Medicine and Hygiene 12:597–603
MechamJ. O.,
TrentD. W.1982a; A comparison of the 26S mRNAs and structural proteins of an equine virulent Venezuelan encephalitis virus and its vaccine derivative. Virology 121:251–261
MechamJ. O.,
TrentD. W.1982b; Glycosylation patterns of the envelope glycoproteins of an equine-virulent Venezuelan equine encephalitis virus and its vaccine derivative. Journal of General Virology 63:121–129
MechamJ. O.,
TrentD. W.1983; A biochemical comparison of the in vitro replication of a virulent and an avirulent strain of Venezuelan encephalitis virus. Journal of General Virology 64:1111–1119
OuJ.-H.,
TrentD. W.,
StraussJ. H.1982a; The 3ʹ-non-coding regions of alphavirus RNAs contain repeating sequences. Journal of Molecular Biology 156:719–730
OuJ.-H.,
RiceC. M.,
DalgarnoL.,
StraussL. E. G.,
Strauss J. H.1982b; Sequence studies of several alphavirus genomic RNAs in the region containing the start of the subgenomic RNA. Proceedings of the National Academy of Sciences, U.S.A 79:5235–5239
PedersonC. E.,
EddyE. A.1974; Separation, isolation, and immunochemical studies of the structural proteins of Venezuelan equine encephalomyelitis virus. Journal of Virology 14:740–744
RoehrigJ. T.,
MathewsJ. H.1985; The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 142:347–356
RoehrigJ. T.,
DayJ. W.,
KinneyR. M.1982; Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 118:269–278
SangerF.,
NicklenS.,
CoulsonA. R.1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
SteinhauerD. A.,
HollandJ. J.1986; Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA. Journal of Virology 57:219–228
StraussE. G.,
StraussJ. H.1986; Structure and replication of the alphavirus genome. In The Togaviruses and Flaviviruses pp. 35–90 Edited by
SchlesingerS.,
SchlesingerM.
New York: Plenum Press;
TignorG. H.,
BurrageT. C.,
SmithA. L.,
ShopeR. E.,
BishopD. H. L.1983; California serogroup gene structure-function relationships: virulence and tissue tropisms. In California Serogroup Viruses pp. 129–138 Edited by
CalisherC. H.,
ThompsonW. H.
New York: Alan R. Liss;
TrentD. W.,
ClewleyJ. P.,
FranceJ. K.,
BishopD. H. L.1979; Immunochemical and oligonucleotide fingerprint analyses of Venezuelan equine encephalomyelitis complex viruses. Journal of General Virology 43:365–381
WaltonT. E.,
JohnsonK. M.1972; Persistence of neutralizing antibody in equidae vaccinated with Venezuelan equine encephalomyelitis vaccine strain TC-83. Journal of the American Veterinary Medical Association 161:916–918
WaltonT. E.,
BrantigamF. E.,
FerrerJ. A.,
JohnsonK. M.1972; Epizootic Venezuelan equine encephalomyelitis in Central America. Disease pattern and vaccine evaluation in Nicaragua, 1969–1970. American Journal of Epidemiology 95:247–254
Molecular Determinants of Alphavirus Neurovirulence: Nucleotide and Deduced Protein Sequence Changes during Attenuation of Venezuelan Equine Encephalitis Virus